Novartis CEO Laments Europe’s Anti-Innovation Atmosphere
Reports Solid If Unspectacular Sales For Q4
Europe does not have a pricing environment that rewards innovation which improves outcomes for patients, according to Vas Narasimhan, although Germany seems to be the best of a bad bunch.
